MCNEIL CONSUMER HIGHER FIRST-QUARTER SALES OFFSET
This article was originally published in The Tan Sheet
Executive Summary
MCNEIL CONSUMER HIGHER FIRST-QUARTER SALES OFFSET by wholesaler inventory reductions affecting Johnson & Johnson Consumer Products and the "fierce competition in the over-the- counter market for vaginal yeast infection remedies encountered by Monistat," J&J said in an April 28 release. As a result, Johnson & Johnson's U.S. consumer sales declined 4.6% to $670 mil.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning